ML-21 Tirabrutinib monotherapy for relapsed/refractory primary central nervous system lymphoma

Backgrounds & purpose: Prognosis of patients with primary central nervous system lymphoma (PCNSL) remains poor despite multiagent immunochemotherapy, and standard of care for relapsed or refractory (r/r) PCNSL has not been established. Recent progresses on molecular genetics and biology of PCNSL...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Autores principales: Kobayashi, Keiichi, Sasaki, Nobuyoshi, Saito, Kuniaki, Yamagishi, Yuki, Matsumoto, Yoshie, Sasaki, Yuta, Shimizu, Saki, Shiokawa, Yoshiaki, Nagane, Motoo
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Supplement Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699110/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.078
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares